WADE ACKERMAN
Partner; Co-Lead, Digital Health Initiative
Covington & Burling LLP
Through nearly two decades of experience in private practice and positions within the FDA and on the Hill, Wade Ackerman provides clients with advice around complex regulatory issues that demand coordinated legal, regulatory, and public policy strategies. He also serves as one of the leaders of Covington’s multidisciplinary Digital Health Initiative, which brings together the firm’s resources across legal, regulatory, commercial, and policy issues relating to innovative digital health technologies.
Ackerman has been actively involved on behalf of the cosmetic industry in efforts to modernize U.S. cosmetics regulation. On December 29, 2022, President Biden signed into law the Modernization of Cosmetics Regulation Act of 2022, which more closely aligns U.S. cosmetics regulation with other areas that FDA regulates. Ackerman was intimately involved in the legislative process around federal cosmetics reform, including by representing the nation’s leading cosmetics trade association, the Personal Care Products Council, in negotiations around the bill.
